FT-005

N/A

Report date: 2023/10/26 16:57:50

Base Information

Drug NameFT-005
Drug Alias NameFT-005FT005
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFrontera Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFrontera Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A